Delivery Order SPE2DR25D1053-SPE2DR26FT441
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,357.98 to AmerisourceBergen Drug Corp for Cortifoam 10% Aerosol 15GM on August 5, 2025, with an ultimate completion date of August 6, 2025. This delivery order represents a firm fixed price transaction with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded and falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cortifoam 10% Aerosol 15GM pharmaceutical product. This non-set-aside, competitively awarded delivery order carries a ceiling value of $6,638.37 under a firm fixed price contract structure, with an ultimate completion date of July 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,204.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cortifoam 10% Aerosol 15GM on September 17, 2025, with an ultimate completion date of September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CORTIFOAM 10% AEROSOL 15GM medical products. The contract has a ceiling value of $15,332.04 and a period of performance through September 24, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide these critical medical...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,259.20, is for the delivery of CORTIFOAM 10% AEROSOL 15GM medical supplies. The contract has a performance period ending on June 11, 2024 and is a firm-fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,195.72 firm fixed-price delivery order is for the supply of CORTIFOAM 10% AEROSOL 15GM, a medical product. The contract has an ultimate completion date of July 30, 2024 and was awarded on July 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $262 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 15 grams of 10% Cortifoam aerosol. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all work to be completed by August 8, 2023 under the terms of the contract. No subcontractors or set aside designations were indicated. The Defense...
- <p>The Defense Logistics Agency awarded a $3,224.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561504123 CORTIFOAM 10% AEROSOL 15GM. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 14-17, 2023. The Defense Logistics Agency supports Department of Defense procurement through contracts for pharmaceuticals and medical supplies. No subcontractors or set aside designations were indicated.</p>
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORTIFOAM 10% AEROS 1S medical supplies, with a firm fixed price of $1,120.92 and a completion date of June 30, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,656.64 for the supply of 4561599390 CORTIFOAM 10% AEROSOL 15GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 26, 2023. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT441Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cortifoam 10% Aerosol 15GM with a ceiling value of $13,200.06 under a firm fixed price contract type. The award was made on October 29, 2025, with an ultimate completion date of October 30, 2025, and no set-aside designation was utilized. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle supports the Defense Health Agency and other federal healthcare systems by enabling flexible procurement of a comprehensive range of pharmaceutical products and medical supplies on a global basis. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills delivery orders for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains through this competitive, competitively awarded contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 10/29/25 |